Dana Kelley

Dana Kelley, MBA, PMP has a diverse work experience spanning over two decades. Starting in 2000 at Akamai Technologies as a Billing Analyst, Dana quickly moved up the ranks and became a Staff Accountant at Biogen Idec, Inc in 2001. During their time at Biogen Idec, Inc, they played a key role in the integration of billing and revenue systems. Dana then worked at Ligand Pharmaceuticals as a Budget Supervisor, where they managed the preparation of annual operating budgets and supervised a team of three. Dana later joined LKQ Corporation as a Senior Manager of Financial Planning & Analysis, where they managed a team of four in the preparation of annual budgets and quarterly financial projections. In 2013, Dana worked at Janssen, Pharmaceutical Companies of Johnson and Johnson as a Summer MBA Intern, where they received a Gold Encore Award for outstanding business partnership. Dana then moved on to GSK as a Director of Finance, managing a multinational team in monthly close and annual planning cycles. In 2015, Dana joined Teva Pharmaceuticals as a Senior Director of Project/Program Management and later became the Director of Finance, overseeing financial performance for a portfolio of 15 specialty branded products. In 2020, they transitioned to Complexa Inc. as a Senior Director of Finance & Administration, responsible for financial forecasting and building critical business partner relationships. Lastly, Dana has recently joined Enveda Biosciences as the VP of Finance in 2023. Throughout their career, Dana has displayed a strong financial background and expertise in project management.

Dana Kelley, MBA, PMP, earned a Master of Business Administration (MBA) degree from Esade from 2012 to 2014. Prior to obtaining an MBA, Dana Kelley attended Skidmore College from 1995 to 1999 where they earned a BA in Business and Economics. Additionally, Dana Kelley obtained a Project Management Professional (PMP) certification from the Project Management Institute in 2017.